NO173486C - Fremgangsmaate for fremstilling av et farmasoeytisk preparat for transdermal administrasjon av legemidler - Google Patents

Fremgangsmaate for fremstilling av et farmasoeytisk preparat for transdermal administrasjon av legemidler

Info

Publication number
NO173486C
NO173486C NO853195A NO853195A NO173486C NO 173486 C NO173486 C NO 173486C NO 853195 A NO853195 A NO 853195A NO 853195 A NO853195 A NO 853195A NO 173486 C NO173486 C NO 173486C
Authority
NO
Norway
Prior art keywords
preparing
procedure
pharmaceutical preparation
drug administration
transdermal drug
Prior art date
Application number
NO853195A
Other languages
English (en)
Norwegian (no)
Other versions
NO853195L (no
NO173486B (no
Inventor
Abraham Fisher
Drora Levy
Michael Y Spiegelstein
Jacob Yaacov Grunwald
Aharon Levy
Moshe Kushnir
Original Assignee
Israel State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Israel State filed Critical Israel State
Publication of NO853195L publication Critical patent/NO853195L/no
Publication of NO173486B publication Critical patent/NO173486B/no
Publication of NO173486C publication Critical patent/NO173486C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO853195A 1984-08-14 1985-08-13 Fremgangsmaate for fremstilling av et farmasoeytisk preparat for transdermal administrasjon av legemidler NO173486C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL72684A IL72684A (en) 1984-08-14 1984-08-14 Pharmaceutical compositions for controlled transdermal delivery of cholinergic or anticholinergic basic drugs

Publications (3)

Publication Number Publication Date
NO853195L NO853195L (no) 1986-02-17
NO173486B NO173486B (no) 1993-09-13
NO173486C true NO173486C (no) 1993-12-22

Family

ID=11055266

Family Applications (1)

Application Number Title Priority Date Filing Date
NO853195A NO173486C (no) 1984-08-14 1985-08-13 Fremgangsmaate for fremstilling av et farmasoeytisk preparat for transdermal administrasjon av legemidler

Country Status (12)

Country Link
US (1) US4788063A (fr)
JP (1) JPS61186317A (fr)
CA (1) CA1260829A (fr)
CH (1) CH667393A5 (fr)
DE (1) DE3528979A1 (fr)
DK (1) DK168585B1 (fr)
FR (1) FR2569112B1 (fr)
GB (1) GB2163347B (fr)
IL (1) IL72684A (fr)
IT (1) IT1221024B (fr)
NO (1) NO173486C (fr)
SE (1) SE462895B (fr)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4680172A (en) * 1985-03-05 1987-07-14 Ciba-Geigy Corporation Devices and methods for treating memory impairment
US4765985A (en) * 1985-03-05 1988-08-23 Ciba-Geigy Corporation Devices and methods for treating memory impairment
US4855290A (en) 1985-05-10 1989-08-08 State Of Israel, Represented By Prime Minister's Office, Israel Institute For Biological Research Derivatives of quinuclidine
US4666926A (en) * 1986-02-27 1987-05-19 Warner-Lambert Company Transdermal formulations
US4908027A (en) * 1986-09-12 1990-03-13 Alza Corporation Subsaturated transdermal therapeutic system having improved release characteristics
US4861800A (en) * 1987-08-18 1989-08-29 Buyske Donald A Method for administering the drug deprenyl so as to minimize the danger of side effects
DE3729299A1 (de) * 1987-09-02 1989-03-23 Beiersdorf Ag Transdermales therapeutisches system
US6107499A (en) * 1988-02-26 2000-08-22 Neuromedica, Inc. Dopamine analog amide
US5994392A (en) 1988-02-26 1999-11-30 Neuromedica, Inc. Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid
GB8807504D0 (en) * 1988-03-29 1988-05-05 Sandoz Ltd Improvements in/relating to organic compounds
US5075312A (en) * 1988-10-27 1991-12-24 Leitman Esther M Novel anti-micturition composition and method
US5075314A (en) * 1988-10-27 1991-12-24 Leitman Esther M Antimicturition composition and novel method
DE3843238C1 (fr) * 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts
DE3843239C1 (fr) 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts
CA2012192A1 (fr) * 1989-03-28 1990-09-28 Munir A. Hussain Administration intranasale de physostigmine et d'arecoline
NZ237241A (en) * 1990-03-02 1993-11-25 Pharmetrix Corp Method for increasing the storage stability of physostigmine
EP0523150A4 (en) * 1990-04-06 1993-09-29 Pharmetrix Corporation Device and method for enhanced administration of physostigmine
US5931774A (en) * 1991-06-14 1999-08-03 Proxima Therapeutics, Inc. Inflatable devices for tumor treatment
US5429582A (en) * 1991-06-14 1995-07-04 Williams; Jeffery A. Tumor treatment
GB9118028D0 (en) * 1991-08-21 1991-10-09 Secr Defence Brit Improved transdrmal formulations
TW224048B (fr) * 1992-03-30 1994-05-21 Hoechst Roussel Pharma
US5612357A (en) * 1992-05-18 1997-03-18 Pharmaco Behavioral Associates, Inc. Use of cotinine to assist in the cessation of tobacco smoking
US5596007A (en) * 1992-05-18 1997-01-21 Pharmaco Behavioral Associates, Inc. Therapeutic method to alleviate the craving associated with cessation of tobacco with cotinine
US5643928A (en) * 1992-10-21 1997-07-01 Pharmaco Behavioral Associates, Inc. Human body weight management
US5869505A (en) * 1993-02-02 1999-02-09 Keenan; Robert M. Nicotine metabolites and nicotine dependence
DE4238223C1 (de) * 1992-11-12 1994-05-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Verabreichung von Physostigmin an die Haut und Verfahren zu dessen Herstellung
US5573774A (en) * 1993-02-02 1996-11-12 Keenan; Robert M. Nicotine metabolites, nicotine dependence and human body weight
DE4313928C2 (de) * 1993-04-28 1996-09-19 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur kontrollierten Abgabe von Pilocarpin an die Haut, Verfahren zu seiner Herstellung und seine Verwendung
DE4342174C1 (de) * 1993-12-10 1995-05-11 Lohmann Therapie Syst Lts Transdermales therapeutisches System sowie ein Verfahren zur Herstellung eines transdermalen therapeutischen Systems zur kombinierten transdermalen Anwendung von Physostigmin und Scopolamin für die Prophylaxe und zur Vorbehandlung einer Vergiftung durch hochtoxische phosphororganische Nervengifte, insbesondere Soman und seine Verwendung
JP3908795B2 (ja) * 1994-11-29 2007-04-25 久光製薬株式会社 ケトチフェン含有経皮投与製剤
US5861431A (en) * 1995-06-07 1999-01-19 Iotek, Inc. Incontinence treatment
DE19533089C1 (de) * 1995-09-07 1997-05-22 Hexal Ag Tacrin-Pflaster
US6576636B2 (en) 1996-05-22 2003-06-10 Protarga, Inc. Method of treating a liver disorder with fatty acid-antiviral agent conjugates
US5795909A (en) * 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
US6479074B2 (en) 1996-10-24 2002-11-12 Pharmaceutical Applications Associates Llc Methods and transdermal compositions for pain relief
US6290986B1 (en) 1996-10-24 2001-09-18 Pharmaceutical Applications Associates, Llc Method and composition for transdermal administration of pharmacologic agents
US6572880B2 (en) 1996-10-24 2003-06-03 Pharmaceutical Applications Associates Llc Methods and transdermal compositions for pain relief
US5977174A (en) * 1997-11-26 1999-11-02 Neuromedica, Inc. Cholinergic compositions and uses thereof
US6197764B1 (en) 1997-11-26 2001-03-06 Protarga, Inc. Clozapine compositions and uses thereof
US6146656A (en) * 1998-01-22 2000-11-14 Nitto Denko Corporation Percutaneous absorption preparation
US6225444B1 (en) 1998-02-10 2001-05-01 Protarga, Inc. Neuroprotective peptides and uses thereof
JP3987655B2 (ja) * 1998-03-03 2007-10-10 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗痴呆薬を含有した経皮適用製剤又は坐剤
US7235583B1 (en) 1999-03-09 2007-06-26 Luitpold Pharmaceuticals, Inc., Fatty acid-anticancer conjugates and uses thereof
US6515003B1 (en) * 1999-08-31 2003-02-04 Maxia Pharmaceuticals, Inc. Heterocyclic derivatives for the treatment of diabetes and other diseases
US7077859B2 (en) 2000-12-22 2006-07-18 Avantec Vascular Corporation Apparatus and methods for variably controlled substance delivery from implanted prostheses
WO2002072009A2 (fr) 2001-03-07 2002-09-19 Maxia Pharmaceuticals, Inc. Derives heterocycliques pour le traitement du cancer et d'autres maladies proliferatives
WO2002072543A2 (fr) * 2001-03-08 2002-09-19 Maxia Pharmaceuticals, Inc. Molecules activant un recepteur rxr
CA2340824A1 (fr) * 2001-03-14 2002-09-14 Ibm Canada Limited-Ibm Canada Limitee Methode et systeme pour l'analyse du comportement des applications
JP4634694B2 (ja) 2001-03-23 2011-02-16 ルイトポルド・ファーマシューティカルズ・インコーポレーテッド 脂肪アルコール薬物複合体
US8552054B2 (en) * 2001-03-23 2013-10-08 Luitpold Pharmaceuticals, Inc. Fatty amine drug conjugates
WO2003016267A1 (fr) * 2001-08-17 2003-02-27 Incyte San Diego Incorporated Derives d'oxime pour le traitement de la dyslipidemie et de l'hypercholesterolemie
JPWO2003028723A1 (ja) * 2001-09-27 2005-01-13 埼玉第一製薬株式会社 縮合イミダゾピリジン誘導体を含む経皮吸収用医薬組成物
WO2003043998A1 (fr) * 2001-11-15 2003-05-30 Incyte San Diego Incorporated Heterocycles n-substitues pour le traitement de l'hypercholesterolemie, de la dyslipidemie et autres troubles du metabolisme, du cancer et de pathologies diverses
AU2003235716A1 (en) * 2002-01-17 2003-07-30 Lts Lohmann Therapie-Systeme Ag Method for neutralizing or recycling carrier materials for film-like coatings
US7102000B2 (en) * 2002-03-08 2006-09-05 Incyte San Diego Inc. Heterocyclic amide derivatives for the treatment of diabetes and other diseases
US7196108B2 (en) * 2002-03-08 2007-03-27 Incyte San Diego Inc. Bicyclic heterocycles for the treatment of diabetes and other diseases
US20040087576A1 (en) * 2002-11-05 2004-05-06 Haracz John L. Antimnemonic therapy for hypermemory syndromes
US20050014767A1 (en) * 2003-01-29 2005-01-20 Magnus Pfahl Benzoxazole, benzothiazole, and benzimidazole derivatives for the treatment of cancer and other diseases
CA2522759A1 (fr) * 2003-04-18 2004-11-04 Incyte San Diego Incorporated Composes isochromane substitues pour le traitement de troubles metaboliques, du cancer et d'autres maladies
DE10338174A1 (de) * 2003-08-20 2005-03-24 Lts Lohmann Therapie-Systeme Ag Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit
TWI372066B (en) 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
US20050182044A1 (en) * 2004-02-17 2005-08-18 Bruinsma Gosse B. Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate
CA2508585A1 (fr) * 2004-06-01 2005-12-01 Axonyx, Inc. Dispositif d'administration transdermique pour le traitement des troubles cognitifs
EP1604686A1 (fr) * 2004-06-08 2005-12-14 Axonyx, Inc. Utilisation de la phenserine et d'un inhibiteur de la HMG CoA reductase pour retarder la progression de la maladie d'Alzheimer
KR20070085838A (ko) * 2004-11-10 2007-08-27 더 트러스티이스 오브 콜롬비아 유니버시티 인 더 시티 오브 뉴욕 운동 장애의 치료 방법
JP2007308403A (ja) * 2006-05-17 2007-11-29 Kenji Yoshida 皮膚外用剤
US20070287727A1 (en) * 2006-06-08 2007-12-13 Jacob Hiller Anti-Nicotine Treatment
WO2009142968A2 (fr) * 2008-05-20 2009-11-26 Olema Pharmaceuticals, Inc. Sels de l'acide valproïque
WO2010048572A1 (fr) 2008-10-23 2010-04-29 Cornell University Nouveau procédé antiviral
LT3650081T (lt) 2013-03-15 2024-06-10 Tonix Pharma Holdings Limited Eutektinės ciklobenzaprino hidrochlorido ir manitolio vaistinės formos
CN111447971A (zh) 2017-12-11 2020-07-24 通尼克斯制药控股有限公司 用于痴呆和神经变性病况中的激越、精神病和认知衰退的环苯扎林治疗

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE521851A (fr) *
GB469526A (en) * 1936-10-02 1937-07-27 Earl Barger Putt Acetyl-salicylic acid composition
AR207805A1 (es) * 1975-02-06 1976-10-29 Alza Corp Substrato apropiado para formar apositos para la dispensacion continua de escopolamina base por via transdermica
NL7806048A (nl) * 1978-06-02 1979-12-04 Kali Chemie Pharma Gmbh Geneesmiddel met betere resorptie-eigenschappen en werkwijze voor de bereiding daarvan.
GB2051574B (en) * 1979-05-10 1984-01-18 Kyoto Pharma Ind Adjuvant for promoting absorption of pharmacologically active substances through the rectum
US4286592A (en) * 1980-02-04 1981-09-01 Alza Corporation Therapeutic system for administering drugs to the skin
NL8104929A (nl) * 1980-11-12 1982-06-01 Alza Corp Anticholinergische preparaten, alsmede de bereiding en de toepassing ervan.
GB2105990B (en) * 1981-08-27 1985-06-19 Nitto Electric Ind Co Adhesive skin patches
DE3204551A1 (de) * 1982-02-10 1983-08-18 Boehringer Ingelheim KG, 6507 Ingelheim Verfahren zur herstellung einer pharmazeutischen zubereitung in form eines polyacrylat-films
JPS58172312A (ja) * 1982-04-02 1983-10-11 Toa Eiyou Kagaku Kogyo Kk ニフエジピン外用剤
JPS59216825A (ja) * 1983-05-23 1984-12-06 Takeda Chem Ind Ltd 経皮吸収外用製剤
EP0127426A1 (fr) * 1983-05-23 1984-12-05 Takeda Chemical Industries, Ltd. Compositions pharmaceutiques percutanées pour application externe
DK243084A (da) * 1983-05-26 1984-11-27 Takeda Chemical Industries Ltd Perkutane farmaceutiske praeparater til udvortes brug
JPS60199834A (ja) * 1984-03-23 1985-10-09 Takeda Chem Ind Ltd 経皮吸収外用製剤
US4568343A (en) * 1984-10-09 1986-02-04 Alza Corporation Skin permeation enhancer compositions

Also Published As

Publication number Publication date
IT1221024B (it) 1990-06-21
JPS61186317A (ja) 1986-08-20
IL72684A (en) 1989-02-28
DK354985D0 (da) 1985-08-05
CA1260829A (fr) 1989-09-26
SE8503664D0 (sv) 1985-08-01
DE3528979A1 (de) 1986-02-27
GB2163347B (en) 1989-01-25
IL72684A0 (en) 1984-11-30
NO853195L (no) 1986-02-17
GB2163347A (en) 1986-02-26
NO173486B (no) 1993-09-13
FR2569112B1 (fr) 1988-10-07
DK168585B1 (da) 1994-05-02
CH667393A5 (de) 1988-10-14
FR2569112A1 (fr) 1986-02-21
GB8519530D0 (en) 1985-09-11
US4788063A (en) 1988-11-29
DK354985A (da) 1986-02-15
SE8503664L (sv) 1986-02-15
SE462895B (sv) 1990-09-17
DE3528979C2 (fr) 1989-12-07
IT8521922A0 (it) 1985-08-12

Similar Documents

Publication Publication Date Title
NO173486C (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat for transdermal administrasjon av legemidler
NO882103D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
NO178564C (no) Framgangsmåte for framstilling av et system for administrering av aktive medikamenter gjennom slimhinner
NO863670D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat av et hydrofobt legemiddel.
NO934897D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
NO883667L (no) Kapsel for farmasoeytisk virksomme innholdsstoffer av en droge.
NO885641L (no) Fremgangsmaate for fremstilling av farmasoeytisk preparat.
NO173213C (no) Fremgangsmaate for fremstilling av et preparat omfattende et liposom
NO892826L (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat for aa forhindre seksuelt overfoerbare sykdommer.
PT86986A (pt) Substituted 9-amino-tetrahydroacridines and related compounds a process for their preparation and their use as medicaments
NO173590C (no) Fremgangsmaate for fremstilling av et stabilt nikorandilholdig farmasoeytisk preparat
NO901232L (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
NO870368D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat med langvarig virkning.
DK645788A (da) Anvendelse af ergolinderivater til fremstilling af et farmaceutisk praeparat
NO883500D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk aktivt nitrometan.
DK79889A (da) Flerlagsplaster til transdermal laegemiddeladministration
NO177485C (no) Fremgangsmåte for fremstilling av et farmasöytisk inhalasjonspreparat
NO179396C (no) Fremgangsmåte ved fremstilling av en medikamentell administreringsform for drövtyggere
NO177126C (no) Fremgangsmåte for fremstilling av et væskeformig farmasöytisk preparat for oral administrering
IT1223343B (it) Formulazioni farmaceutiche per somministrazione transdermica
DK689188A (da) Anvendelse af piperidin-derivater til fremstilling af et farmaceutisk praeparat
DK298389D0 (da) Farmaceutisk praeparat til topisk anvendelse omfattende et amin-funktionelt medikament
DK154607C (da) Fremgangsmaade til fremstilling af en laegemiddelform til oral administration af ergotalkaloider
NO164239C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt karbapenemderivat.
NO874539D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat